Capital for the RTP bench.
Equipment, venture-aligned debt and working capital for the biotech, pharma and life-sciences operators across Research Triangle Park, Durham and Morrisville.
Biotech and life sciences in the Triangle run on a deep bench of anchors - Research Triangle Park, Duke University, UNC, NC State, and the contract manufacturing footprint of Novo Nordisk in Apex and FUJIFILM Diosynth in RTP. Operators here range from early-stage therapeutics and diagnostics out of Duke and UNC labs to growth-stage CDMOs, CROs and lab-services companies billing global pharma primes. Financing this sector requires lenders who understand milestone-driven revenue, venture-aligned debt and lab-equipment collateral.
Equipment financing covers the heavy capex base - bioreactors, chromatography systems, cold-storage, mass spec, automated liquid handlers and full clean-room build-outs. The equipment is the collateral and the structure aligns to the development timeline of the program. Venture debt and revenue-based facilities fit growth-stage operators with proven contracts but pre-profit P&Ls. AR financing against pharma-prime receivables bridges the long payment cycles common in CRO and CDMO billing.
Quincy pre-screens by program stage, customer concentration and capital stack. A pre-clinical therapeutic with NIH grants and venture backing is a different lender profile than a profitable RTP CDMO with three years of clean financials, and both differ from a lab-services company billing Duke Health and UNC. The right lender for each lives in a different corner of the venture-debt, equipment-finance and AR-lending bench.
Every option starts with a soft credit pull. Pre-screen takes 60 seconds.
RTP-based startups and contract manufacturers
Lab equipment, cleanroom build-outs, working capital and bridge financing aligned to milestone-driven revenue cycles.
Mass spec, centrifuges, bioreactors
Finance new and used lab equipment with the equipment itself as collateral - preserving runway for headcount.
Non-dilutive growth capital
Capital priced as a fixed multiple, repaid as a percentage of monthly revenue. Sized for SaaS-adjacent and tools-based life-sciences operators.
Revolving line on the AR ledger
A revolving facility secured by your receivables - for contract manufacturers and life-sciences services with consistent invoice volume.
